Using albumin to improve the therapeutic properties of diabetes treatments-Reference-Cited by-同舟云学术

Using albumin to improve the therapeutic properties of diabetes treatments

Published:2011-11-22 Issue:2 Volume:14 Page:121-129
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Ahrén B.,Burke B.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2011.01482.x/fullpdf

Reference89 articles.

1. International Diabetes Federation. The global burden: epidemiology and morbidity. 2010 http://www.diabetesatlas.org/content/epidemiology-and-morbidity

2. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.;Vague;Diabetes Care,2003

3. GLP-1 for type 2 diabetes.;Ahren;Exp Cell Res,2011

4. The physiology of glucagon-like peptide 1.;Holst;Physiol Rev,2007

5. The extraordinary ligand binding properties of human serum albumin.;Fasano;IUBMB Life,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Advances in Fusion Protein-Based Drugs for Diabetes Treatment;Diabetes, Metabolic Syndrome and Obesity;2024-01

2. Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy;Diabetologia;2023-05-20

3. Preclinical pharmacology of RA15127343 : In vitro and in vivo activity of a novel ultralong‐acting basal insulin;Diabetes, Obesity and Metabolism;2022-08-16

4. Synthesis and Evaluation of the Insulin–Albumin Conjugate with Prolonged Glycemic Control;ACS Omega;2022-02-02

5. KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs;Journal of Controlled Release;2019-02